← FDA ENFORCEMENT
D-0327-2026Class II

F.H. INVESTMENTS, Inc. (dba Asteria Health)

Recalling firm
F.H. INVESTMENTS, Inc. (dba Asteria Health)
Product type
Drug
Status
Ongoing
Report date
2026-02-18
Distribution
Nationwide in the USA
Firm state
AL
Product quantity
670 pellets
Initiated by
Voluntary: Firm initiated
SPEQ quality domain
Environmental Monitoring
Reason for recall

Presence of Foreign substance - potential presence of metal particulate matter

Product description

Testosterone 75mg, Anastrozole 4mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-4079-32.

Code / lot info

Lot#: 254000107, Exp. 06/30/2026; 254000111, Exp. 08/07/2026. .

Other recalls SPEQ maps to Environmental Monitoring
2026-07-22Class IFrutas y Hortalizas del Sur S.A.2026-07-22Class IIGELLERT GLOBAL GROUP2026-07-22Class IIChiesi USA, Inc.2026-07-22Class IICareFusion 213, LLC
See all Environmental Monitoring recalls →

Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.